IP Library Granted Patent US 8,926,699
Granted Patent B2
US 8,926,699 · App. 13/360,694 · Granted Jan 6, 2015

Composite bone graft kit

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,926,699
App. No.
13/360,694
Granted
Jan 6, 2015
Kind
B2
Abstract

A composite bone graft which comprises an allograft bone component; a synthetic bone substitute, wherein the synthetic bone substitute is in contact with the allograft bone component. The composite is arranged in a core/outer layer structure.

Claims (10)

1. A composite bone graft comprising:

an allograft bone component;

a cylindrical shell; and

a synthetic bone substitute, wherein the synthetic bone substitute is in contact with the allograft bone component and further comprising a resorbable mesh casing, wherein the composite bone graft is disposed within the resorbable mesh casing and the resorbable mesh casing holds the composite bone graft together and prevents dissipation of the composite bone graft, wherein the composite bone graft is in the form of a cylinder with an inner core and outer layer, and wherein the inner core is disposed within the cylindrical shell and the outer layer is disposed on the outside of the cylindrical shell.

2. The composite of claim 1 , wherein the inner core is composed of the allograft bone component and the outer layer is composed of the synthetic bone substitute.

3. The composite of claim 1 , wherein the inner core is composed of the synthetic bone substitute and the outer layer is composed of the allograft bone component.

4. The composite of claim 1 wherein the allograft bone component and synthetic bone substitute are at least partially infused with an additive, wherein the additive is one or more of platelet rich plasma, bone marrow aspirate, or stem cells.

5. The composite of claim 1 , further comprising a bone graft syringe, wherein the composite bone graft is positioned within the bone graft syringe.

6. The composite of claim 1 , wherein the synthetic bone substitute is as beta-tricalcium phosphate, hydroxyapetite, polyglycolic-polylactid acid, or poly-lactic acid; and wherein the allograft bone is in the form of dense cortical bone strips, packed bone chips, or demineralized bone matrix.

7. The composite of claim 1 , wherein the inner core is 5 to 15 mm in diameter and the outer layer is 2 to 15 mm in thickness.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2019
From: AMERICAN BANK
To: SPINESMITH HOLIDNGS, LLC
Reel/Frame 048853/0105 →
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2019
From: SILICON VALLEY BANK
To: SPINESMITH HOLDINGS, LLC
Reel/Frame 048853/0183 →
SECURITY INTEREST Recorded Apr 9, 2019
From: SPINESMITH HOLDINGS, LLC
To: BLUEARC MEZZANINE PARTNERS I, LP
Reel/Frame 048839/0655 →
SECURITY INTEREST Recorded Dec 14, 2017
From: SPINESMITH HOLDINGS, LLC
To: AMERICAN BANK, N.A.
Reel/Frame 044882/0096 →
SECURITY INTEREST Recorded Mar 22, 2017
From: SPINESMITH HOLDINGS, LLC
To: BLUEARC MEZZANINE PARTNERS I, L.P.
Reel/Frame 042071/0370 →
SECURITY INTEREST Recorded Feb 18, 2015
From: SPINESMITH HOLDINGS, LLC
To: SILICON VALLEY BANK
Reel/Frame 035014/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2012
From: BURKINSHAW, BRIAN
To: SPINESMITH PARTNERS, LP
Reel/Frame 028043/0626 →